SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (DNLI) today reported financial results for the fourth quarter and year ended December 31, 2024, and provided ...
ETV offers a balanced approach with capital appreciation and consistent income through a diverse equity portfolio and option writing strategy. ETV's price stability, experienced management, and ...
Tividenofusp alfa BLA review process for accelerated approval for MPS II continues with productive engagement with the FDA; commercial launch ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback